Silent Atrial Fibrillation and Cryptogenic Strokes

被引:27
作者
Dalen, James E. [1 ]
Alpert, Joseph S. [1 ]
机构
[1] Univ Arizona, Dept Med, Tucson, AZ 85724 USA
关键词
Anticoagulation for silent atrial fibrillation; Cryptogenic strokes; ECG monitoring; Silent atrial fibrillation; PATENT FORAMEN OVALE; TRANSIENT ISCHEMIC ATTACK; ANTICOAGULANT-THERAPY; AMERICAN-COLLEGE; CHEST PHYSICIANS; RISK; PREVENTION; CARDIOVERSION; METAANALYSIS; POPULATION;
D O I
10.1016/j.amjmed.2016.09.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A new suspected cause of cryptic strokes is "silent atrial fibrillation." Pacemakers and other implanted devices allow continuous recording of cardiac rhythm for months or years. They have discovered that short periods of atrial fibrillation lasting minutes or hours are frequent and usually are asymptomatic. A meta-analysis of 50 studies involving more than 10,000 patients with a recent stroke found that 7.7% had new atrial fibrillation on their admitting electrocardiogram. In 3 weeks during and after hospitalization, another 16.9% were diagnosed. A total of 23.7% of these stroke patients had silent atrial fibrillation; that is, atrial fibrillation diagnosed after hospital admission. Silent atrial fibrillation is also frequent in patients with pacemakers who do not have a recent stroke. In a pooled analysis of 3 studies involving more than 10,000 patients monitored for 24 months, 43% had at least 1 day with atrial fibrillation lasting more than 5 minutes. Ten percent had atrial fibrillation lasting at least 12 hours. Despite the frequency of silent atrial fibrillation in these patients with multiple risk factors for stroke, the annual incidence of stroke was only 0.23%. When silent atrial fibrillation is detected in patients with recent cryptogenic stroke, anticoagulation is indicated. In patients without stroke, silent atrial fibrillation should lead to further monitoring for clinical atrial fibrillation rather than immediate anticoagulation, as some have advocated. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:264 / 267
页数:4
相关论文
共 28 条
[1]   Thromboembolic Complications After Cardioversion of Acute Atrial Fibrillation The FinCV (Finnish CardioVersion) Study [J].
Airaksinen, K. E. Juhani ;
Gronberg, Toni ;
Nuotio, Ilpo ;
Nikkinen, Marko ;
Ylitalo, Antti ;
Biancari, Fausto ;
Hartikainen, Juha E. K. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (13) :1187-1192
[2]   Device-detected atrial fibrillation and risk for stroke: an analysis of > 10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices) [J].
Boriani, Giuseppe ;
Glotzer, Taya V. ;
Santini, Massimo ;
West, Teena M. ;
De Melis, Mirko ;
Sepsi, Milan ;
Gasparini, Maurizio ;
Lewalter, Thorsten ;
Camm, John A. ;
Singer, Daniel E. .
EUROPEAN HEART JOURNAL, 2014, 35 (08) :508-516
[3]   Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes [J].
Connolly, SJ ;
Kerr, CR ;
Gent, M ;
Roberts, RS ;
Yusuf, S ;
Gillis, AM ;
Sami, MH ;
Talajic, M ;
Tang, ASL ;
Klein, GJ ;
Lau, C ;
Newman, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (19) :1385-1391
[4]   Are patients with a patent foramen ovale at increased risk of stroke? A billion dollar question [J].
Dalen, James E. .
AMERICAN JOURNAL OF MEDICINE, 2007, 120 (06) :472-474
[5]   Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment? [J].
Dalen, James E. ;
Alpert, Joseph S. .
AMERICAN JOURNAL OF MEDICINE, 2016, 129 (11) :1159-1162
[6]   Prevention of Embolic Strokes The Role of the American College of Chest Physicians [J].
Dalen, James E. .
CHEST, 2012, 141 (02) :294-299
[7]   Patent foramen ovale and the risk of ischemic stroke in a multiethnic population [J].
Di Tullio, Marco R. ;
Sacco, Ralph L. ;
Sciacca, Robert R. ;
Jin, Zhezhen ;
Homma, Shunichi .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (07) :797-802
[8]   Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study [J].
DiMarco, JP ;
Flaker, G ;
Waldo, AL ;
Corley, SD ;
Greene, HL ;
Safford, RE ;
Rosenfeld, LE ;
Mitrani, G ;
Nemeth, M .
AMERICAN HEART JOURNAL, 2005, 149 (04) :650-656
[9]   Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey [J].
Dobreanu, Dan ;
Svendsen, Jesper Hastrup ;
Lewalter, Thorsten ;
Hernandez-Madrid, Antonio ;
Lip, Gregory Y. H. ;
Blomstrom-Lundqvist, Carina .
EUROPACE, 2013, 15 (08) :1223-1225
[10]   Atrial Fibrillation in Patients with Cryptogenic Stroke [J].
Gladstone, David J. ;
Spring, Melanie ;
Dorian, Paul ;
Panzov, Val ;
Thorpe, Kevin E. ;
Hall, Judith ;
Vaid, Haris ;
O'Donnell, Martin ;
Laupacis, Andreas ;
Cote, Robert ;
Sharma, Mukul ;
Blakely, John A. ;
Shuaib, Ashfaq ;
Hachinski, Vladimir ;
Coutts, Shelagh B. ;
Sahlas, Demetrios J. ;
Teal, Phil ;
Yip, Samuel ;
Spence, J. David ;
Buck, Brian ;
Verreault, Steve ;
Casaubon, Leanne K. ;
Penn, Andrew ;
Selchen, Daniel ;
Jin, Albert ;
Howse, David ;
Mehdiratta, Manu ;
Boyle, Karl ;
Aviv, Richard ;
Kapral, Moira K. ;
Mamdani, Muhammad .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (26) :2467-2477